Screener
Lexicon Pharmaceuticals LXRX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's restricted cash?
- Lexicon Pharmaceuticals (LXRX) reported restricted cash of $0 in Q2 2026.
- How has Lexicon Pharmaceuticals's restricted cash changed year-over-year?
- Lexicon Pharmaceuticals's restricted cash decreased by 100.0% year-over-year, from $29M to $0.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Lexicon Pharmaceuticals's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude